1. Home
  2. MBOT vs BTCS Comparison

MBOT vs BTCS Comparison

Compare MBOT & BTCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

HOLD

Current Price

$2.28

Market Cap

126.3M

Sector

Health Care

ML Signal

HOLD

Logo BTCS Inc.

BTCS

BTCS Inc.

HOLD

Current Price

$3.04

Market Cap

148.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBOT
BTCS
Founded
2010
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
126.3M
148.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MBOT
BTCS
Price
$2.28
$3.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$8.75
$7.00
AVG Volume (30 Days)
3.0M
1.4M
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
1.55%
EPS Growth
N/A
644.42
EPS
N/A
1.76
Revenue
N/A
$11,724,983.00
Revenue This Year
N/A
$248.05
Revenue Next Year
$2,166.67
$41.01
P/E Ratio
N/A
$1.83
Revenue Growth
N/A
464.28
52 Week Low
$0.93
$1.25
52 Week High
$4.67
$8.49

Technical Indicators

Market Signals
Indicator
MBOT
BTCS
Relative Strength Index (RSI) 48.70 43.71
Support Level $2.31 $3.28
Resistance Level $2.55 $3.63
Average True Range (ATR) 0.17 0.22
MACD 0.03 0.05
Stochastic Oscillator 59.15 17.93

Price Performance

Historical Comparison
MBOT
BTCS

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.

About BTCS BTCS Inc.

BTCS Inc. ("BTCS" or the "Company"), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance ("DeFi") and traditional finance ("TradFi") mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at www.btcs.com.

Share on Social Networks: